Come up with a name for your new list and we'll add to it:
CutisPharma raised a round of funding on March 26, 2018. Investors include
NovaQuest Capital Management.
CutisPharma is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compou…